ALL (Acute Lymphoblastic Leukemia),Leukemia Myeloablative Chemo-based Conditioning Shows Low Toxicity For Children With ALL Oct 11, 2023
CML (Chronic Myeloid Leukemia),Leukemia Optimal Dosing of Selumetinib and Azacitidine in Higher-Risk Chronic Myeloid Neoplasia Patients Oct 10, 2023
AML (Acute Myeloid Leukemia),Leukemia Venetoclax-FLAI Improves Survival in Intermediate/High-Risk AML Oct 09, 2023
CML (Chronic Myeloid Leukemia),Leukemia Asciminib Show Deep Responses In Patients With CML‑CP Oct 06, 2023
AML (Acute Myeloid Leukemia),Leukemia Standard Chemo + Quizartinib Vs. Placebo In Newly Diagnosed FLT3-ITD WT AML Patients Oct 03, 2023
AML (Acute Myeloid Leukemia),Leukemia Combined Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome Sep 29, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Ponatinib Found Superior to Imatinib in Newly Diagnosed Philadelphia Chromosome‑Positive ALL Sep 25, 2023
AML (Acute Myeloid Leukemia) FLT3 Inhibitor Gilteritinib Trial for Post-Transplant Maintenance in FLT3-ITD AML Sep 19, 2023
